Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus.
A subset of HIV-1-infected patients known as elite controllers or suppressors (ES) control the virus naturally. We have previously demonstrated sequence discordance between proviral and plasma gag clones in ES, much of which can be attributed to selective pressure from the host (J. R. Bailey, T. M. Williams, R. F. Siliciano, and J. N. Blankson, J. Exp. Med. 203:1357-1369, 2006). However, it is not clear whether ongoing viral replication continues in ES once the control of viremia has been established or whether selective pressure impacts this evolution. The cytotoxic T-lymphocyte (CTL) response in ES often targets Gag and frequently is superior to that of HIV-1 progressors, partially due to the HLA class I alleles B*57/5801 and B*27, which are overrepresented in ES. We therefore examined longitudinal plasma and proviral gag sequences from HLA-B*57/5801 and -B*27 ES. Despite the highly conserved nature of gag, we observed clear evidence of evolution in the plasma virus, largely due to synonymous substitutions. In contrast, evolution was rare in proviral clones, suggesting that ongoing replication in ES does not permit the significant reseeding of the latent reservoir. Interestingly, there was little continual evolution in CTL epitopes, and we detected de novo CTL responses to autologous viral mutants. Thus, some ES control viremia despite ongoing replication and evolution.
O'Connell
Karen A
KA
Broadway Research Bldg., Rm 880, Johns Hopkins University School of Medicine, 733 N. Broadway, Baltimore, MD 21205, USA.
Brennan
Timothy P
TP
Bailey
Justin R
JR
Ray
Stuart C
SC
Siliciano
Robert F
RF
Blankson
Joel N
JN
D000595:Amino Acid Sequence; D000939:Epitopes; D019143:Evolution, Molecular; D015658:HIV Infections / Q000276:immunology* / Q000503:physiopathology / Q000821:virology*; D020276:HIV Long-Term Survivors; D015497:HIV-1 / Q000145:classification / Q000235:genetics / Q000276:immunology / Q000502:physiology*; D015235:HLA-B Antigens / Q000235:genetics / Q000276:immunology; D006801:Humans; D008969:Molecular Sequence Data; D010802:Phylogeny; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D019562:Viral Load; D014766:Viremia / Q000276:immunology / Q000821:virology; D014779:Virus Replication
D000939:Epitopes; D015235:HLA-B Antigens; C484830:HLA-B*57:01 antigen; C500126:HLA-B*58:01 antigen
AIDS. 2005 Nov 18;19(17):2001-7
16260907
Immunity. 2008 Dec 19;29(6):1009-21
19062316
J Infect Dis. 2008 Feb 15;197(4):563-71
18275276
J Virol. 2007 Nov;81(22):12608-18
17728232
Nat Med. 2004 Mar;10(3):282-9
14770175
Nat Immunol. 2002 Nov;3(11):1061-8
12368910
J Immunol. 2009 Jun 15;182(12):7828-37
19494307
Nat Rev Immunol. 2004 Aug;4(8):630-40
15286729
Nat Med. 2006 Dec;12(12):1365-71
17115046
J Virol. 2008 Jun;82(11):5594-605
18385228
J Exp Med. 2006 May 15;203(5):1357-69
16682496
J Virol. 2008 Sep;82(18):9216-27
18614631
J Infect Dis. 2008 Jan 1;197(1):126-33
18171295
Clin Infect Dis. 2008 Apr 15;46(8):e78-82
18444844
PLoS Genet. 2009 Mar;5(3):e1000431
19300501
J Virol. 2008 Aug;82(15):7395-410
18495769
J Virol. 2009 Sep;83(17):8470-81
19535437
J Virol. 2006 Jul;80(13):6441-57
16775332
Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2709-14
10694578
Trends Pharmacol Sci. 2009 Dec;30(12):631-7
19837464
J Infect Dis. 2009 Sep 15;200(6):984-90
19656066
J Virol. 2009 Jan;83(1):329-35
18945778
AIDS. 2009 Jun 1;23(9):1163-9
19444075
J Exp Med. 2009 Jun 8;206(6):1253-72
19487423
Mol Biol Evol. 1986 Sep;3(5):418-26
3444411
Clin Infect Dis. 2005 Oct 1;41(7):1053-6
16142675
J Infect Dis. 2009 Dec 15;200(12):1820-4
19909081
JAMA. 2005 Feb 16;293(7):817-29
15713771
Mol Biol Evol. 2007 Aug;24(8):1596-9
17488738
Clin Infect Dis. 2008 Jul 1;47(1):102-4
18494606
J Virol. 1999 Dec;73(12):10489-502
10559367
J Exp Med. 2007 Oct 1;204(10):2473-85
17893201
Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6776-81
17428922
Blood. 2006 Jun 15;107(12):4781-9
16467198
Virology. 2003 Jul 20;312(1):135-50
12890627
J Virol. 2006 Apr;80(7):3617-23
16537629
J Virol. 2003 Jun;77(12):6889-98
12768008
J Virol. 2008 Jun;82(11):5398-407
18353945
AIDS. 2008 Feb 19;22(4):541-4
18301071
J Virol. 2007 Mar;81(5):2508-18
17151109
J Virol. 2009 Jan;83(1):88-97
18945771
Clin Infect Dis. 2010 Mar 15;50(6):912-9
20156060
J Virol. 2007 Aug;81(15):8346-51
17507468
J Acquir Immune Defic Syndr. 2009 Apr 1;50(4):403-8
19214118